Amgen Joins China Oncology Market Race With $2.7bn BeiGene Stake

 
• By Brian Yang
  
China
AMGEN INVESTS $2.7bn IN BEIJING-BASED BEIGENE TO SEIZE CHINA ONCOLOGY MARKET OPPORTUNITIES • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia